H.R. 1691 · 118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Stage
Reported from committee
Sponsor
Brad Wenstrup
Introduced
2023-03-22
Latest action
2024-12-24 · Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-952, Part I.

Action history

  1. 2024-12-24Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-952, Part I.
  2. 2024-12-24Committee on Energy and Commerce discharged.
  3. 2024-12-24Placed on the Union Calendar, Calendar No. 801.
  4. 2024-06-27Committee Consideration and Mark-up Session Held
  5. 2024-06-27Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 36 - 5.
  6. 2023-11-15Subcommittee Consideration and Mark-up Session Held
  7. 2023-11-15Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 21 - 6.
  8. 2023-03-31Referred to the Subcommittee on Health.
  9. 2023-03-22Introduced in House
  10. 2023-03-22Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  11. 2023-03-22Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.